Mircera and Calcium acetate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mircera (methoxy polyethylene glycol-epoetin beta) and Calcium acetate (calcium acetate). Common drug interactions include drug hypersensitivity among females and drug hypersensitivity among males.

The phase IV clinical study analyzes what interactions people have when they take Mircera and Calcium acetate. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Mircera?

Mircera has active ingredients of methoxy polyethylene glycol-epoetin beta. eHealthMe is studying from 10,321 Mircera users. Check the latest studies of Mircera.

What is Calcium acetate?

Calcium acetate has active ingredients of calcium acetate. It is often used in osteoporosis. eHealthMe is studying from 3,076 Calcium acetate users. Check the latest studies of Calcium acetate.

On Jul, 16, 2026

21 people who take Mircera and Calcium acetate together, and have interactions are studied.

Mircera and Calcium acetate drug interactions.

What are the common drug interactions of Mircera and Calcium Acetate, by gender? *:

female:

Drug hypersensitivity
Feeling hot
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Hydronephrosis (water inside the kidney)
Leukopenia (less number of white blood cells in blood)
Abdominal pain
Device related infection
Diarrhoea
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Gastrointestinal pain

male:

Drug hypersensitivity
Haemoglobin decreased
Chest discomfort
Chest pain
Dyspnoea (difficult or laboured respiration)
Feeling hot
Flushing (the warm, red condition of human skin)
Hyperhidrosis (abnormally increased sweating)
Hypersensitivity
Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Mircera and Calcium Acetate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Haemoglobin decreased
Myocarditis (inflammation of heart muscle myocardium)

40-49:

Abdominal pain upper
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Anxiety
Chest discomfort
Chest pain
Drug hypersensitivity
Dyspnoea (difficult or laboured respiration)
Feeling hot
Flushing (the warm, red condition of human skin)
Hyperhidrosis (abnormally increased sweating)

50-59:

Rash
Wound haemorrhage (bleeding wound)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Chronic kidney disease
Depression
Device related infection
Emotional distress
Pain
Renal failure (kidney dysfunction)

60+:

Drug hypersensitivity
Hydronephrosis (water inside the kidney)
Venous stenosis (abnormal narrowing of veins)
Feeling hot
Headache (pain in head)
Hypotension (abnormally low blood pressure)
Retrograde amnesia (a loss of memory-access to events that occurred, or information that was learned, before an injury or the onset of a disease)

What are the existing conditions these people have? *

Nephrogenic Anaemia (anaemia due to kidney disease): 10 people, 47.62%
Iron Deficiency: 2 people, 9.52%
Chronic Renal Failure (kidney failure): 2 people, 9.52%
Anaemia (lack of blood): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Mircera and Calcium acetate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously